To elucidate the mechanism by which RUNXOR regulates the immunosuppression of MDSCs, we detected the expression of a potential target gene of RUNXOR, RUNX1, in the blood samples of lung cancer patients and found that the RUNX1 level was downregulated in the peripheral blood of lung cancer patients compared with that of healthy controls. Here, RUNX1 is linked to lung carcinoma.